Table III.
Incidence of TdT-negative, CD34-negative and TdT/CD34 Double-negative ALL in present study and reported in other studies.
| Antigens | Present study results, n/N (%) | Other studies | |
|---|---|---|---|
| TdT- | 41/843 (4.8) | 11.4%25, 38%22 | |
| B-ALL | CD34- | 314/833 (37.6) | 41%26, 44%22 |
| CD34-/TdT- | 23/826 (2.8) | 5.7%25 | |
| TdT- | 35/206 (16.9) | 28.5%25, 57%22 | |
| T-ALL | CD34- | 149/200 (74.5) | 78%22 |
| CD34-/TdT- | 22/198 (11) | 0.5%27 |
n/N: No. of cases lacking the tested expression/ Total no. of cases tested